Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
Farooq Syed(Indiana University – Purdue University Indianapolis), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Stéphane Demine(Indiana Biosciences Research Institute), Kara S. Orr(Indiana University – Purdue University Indianapolis), Maria Inês Alvelos(Université Libre de Bruxelles), Ângela Castela(Université Libre de Bruxelles), Preethi Krishnan(Diabetes Australia), Alexandra Coomans de Brachène(Université Libre de Bruxelles), Arnaud Zaldumbide(Leiden University Medical Center), Lorella Marselli(University of Pisa), Staci A. Weaver(Indianapolis Zoo), Décio L. Eizirik(Université Libre de Bruxelles), Sofia Thomaidou, Donalyn Scheuner(Indiana Biosciences Research Institute), Jing Liu(Liaoning University of Traditional Chinese Medicine), Garrick Chang(Indiana University Indianapolis), Jyoti Rana(Indiana University – Purdue University Indianapolis), Olivia Ballew(Indiana Biosciences Research Institute), Namratha Shivani Chalasani(Indiana University School of Medicine), Piero Marchetti(University of Pisa), Chih‐Chun Lee(Diabetes Australia), Jamie L. Felton(University School)
Cited by 3
Related Papers
The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus
|Endocrine Reviews|2007|1.2k
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522
The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines
|PLoS Genetics|2012|474